United States (NYSE / NASDAQ)i
Disclosure rulesInsider tradingForm 4 (SEC §16): officers, directors, and 10%+ shareholders must file within 2 business days of each transaction. One filing per trade. Foreign Private Issuers exempt until 18 March 2026 — new SEC rule extends §16(a) to FPI directors and officers.
BuybacksItem 703 of Regulation S-K: aggregated MONTHLY, disclosed in the quarterly 10-Q (and annual 10-K), filed 30-45 days after quarter end. Not per-trade — you see one row per fiscal quarter (we segregate YTD into isolated quarters).
Verified 2026-05-30
i
Disclosure rules
Insider trading
Form 4 (SEC §16): officers, directors, and 10%+ shareholders must file within 2 business days of each transaction. One filing per trade. Foreign Private Issuers exempt until 18 March 2026 — new SEC rule extends §16(a) to FPI directors and officers.
Buybacks
Item 703 of Regulation S-K: aggregated MONTHLY, disclosed in the quarterly 10-Q (and annual 10-K), filed 30-45 days after quarter end. Not per-trade — you see one row per fiscal quarter (we segregate YTD into isolated quarters).
Verified 2026-05-30
Feed refreshed 3 Aug 2026, 19:32 ET
Reporting lag: US buybacks come from quarterly 10-Q filings (filed 30 to 45 days after quarter-end), so the newest one here reflects a past quarter, not the latest week. That's the SEC reporting cadence, not a stale feed. Most recent filing shown: 2026-07-05.
Top 5 Buybacks (by consideration)
- 85AAPLApple Inc.4 filings$81.8B2.09% o/s
- 89NVDANVIDIA CORP3 filings$36.4B0.82% o/s
- 86CRMSalesforce, Inc.3 filings$35B
- 59JPMJPMORGAN CHASE & CO3 filings$24.9B
- 70BACBofA Finance LLC4 filings$24.9B
| Ticker / Name | Rank | Filings | Total shares | Total consideration | % o/s | Latest |
|---|---|---|---|---|---|---|
85 | 4 | 305,000,000 | $81.8B | 2.09% | 2026-06-27 | |
89 | 3 | 198,000,000 | $36.4B | 0.82% | 2026-04-26 | |
86 | 3 | — | $35B | — | 2026-04-30 | |
59 | 3 | — | $24.9B | — | 2026-03-31 | |
70 | 4 | — | $24.9B | — | 2026-06-30 |
Sort
SHW
THE SHERWIN-WILLIAMS COMPANY
2026-06-30
67
Shares
4,000,000
Price
$315.35
Consid.
$1.3B
% o/s
1.65%
REGN
REGENERON PHARMACEUTICALS, INC.
2026-06-30
84
Shares
1,700,000
Price
$685.00
Consid.
$1.2B
% o/s
—
| Ticker / Name | Price | Source | |||||
|---|---|---|---|---|---|---|---|
| 2026-07-05 | 81 | — | — | $1.7M | — | filing → | |
| 2026-07-04 | 80 | 3,265,149 | — | $252.1M | 2.16% | filing → | |
| 2026-07-04 | 66 | — | — | $209M | — | filing → | |
| 2026-07-04 | 94 | 735,873 | $137.12 | $100.9M | 1.49% | filing → | |
| 2026-07-04 | 91 | 241,000 | $379.25 | $91.4M | 0.47% | filing → | |
| 2026-07-04 | 78 | — | — | $59.9M | — | filing → | |
| 2026-07-03 | 68 | — | — | $331.9M | — | filing → | |
| 2026-07-03 | 35 | 700,000 | — | $229M | 0.38% | filing → | |
| 2026-07-03 | 51 | 1,600,000 | $63.13 | $101M | 1.45% | filing → | |
| 2026-07-03 | 64 | 733,346 | $34.09 | $25M | 0.58% | filing → | |
| 2026-06-30 | 70 | — | — | $6B | — | filing → | |
| 2026-06-30 | 57 | — | — | $4.9B | — | filing → | |
| 2026-06-30 | 47 | — | — | $4.7B | — | filing → | |
| 2026-06-30 | 70 | — | — | $4.6B | — | filing → | |
| 2026-06-30 | 38 | 4,100,000 | $975.61 | $4B | 1.41% | filing → | |
| 2026-06-30 | 55 | 2,500,000 | $949.20 | $2.4B | 0.94% | filing → | |
| 2026-06-30 | 54 | — | — | $2.3B | — | filing → | |
| 2026-06-30 | 82 | — | — | $2.3B | — | filing → | |
| 2026-06-30 | 82 | — | — | $2.3B | — | filing → | |
| 2026-06-30 | 31 | — | — | $2.2B | — | filing → | |
| 2026-06-30 | 75 | 86,000,000 | $25.31 | $2.2B | 1.26% | filing → | |
| 2026-06-30 | 53 | 6,900,000 | $291.59 | $2B | 0.67% | filing → | |
| 2026-06-30 | 71 | — | — | $2B | — | filing → | |
| 2026-06-30 | 92 | — | — | $1.6B | — | filing → | |
| 2026-06-30 | 96 | 4,300,000 | $302.33 | $1.3B | 2.06% | filing → | |
| 2026-06-30 | 67 | 4,000,000 | $315.35 | $1.3B | 1.65% | filing → | |
| 2026-06-30 | 77 | — | — | $1.2B | — | filing → | |
| 2026-06-30 | 67 | — | — | $1.2B | — | filing → | |
| 2026-06-30 | 84 | 1,700,000 | $685.00 | $1.2B | — | filing → | |
| 2026-06-30 | 64 | — | — | $1.1B | — | filing → | |
| 2026-06-30 | 65 | — | — | $1.1B | — | filing → | |
| 2026-06-30 | 99 | — | — | $1.1B | — | filing → | |
| 2026-06-30 | 68 | — | — | $1B | — | filing → | |
| 2026-06-30 | 86 | 21,289,443 | — | $1B | 0.51% | filing → | |
| 2026-06-30 | 69 | — | — | $991M | — | filing → | |
| 2026-06-30 | 61 | — | — | $940M | — | filing → | |
| 2026-06-30 | 63 | — | — | $873M | — | filing → | |
| 2026-06-30 | 51 | — | — | $859M | — | filing → | |
| 2026-06-30 | 58 | 5,642,927 | $151.52 | $855M | — | filing → | |
| 2026-06-30 | 62 | 15,034,456 | $52.95 | $796M | 2.32% | filing → | |
| 2026-06-30 | 54 | — | — | $757M | — | filing → | |
| 2026-06-30 | 40 | — | — | $694M | — | filing → | |
| 2026-06-30 | 56 | — | — | $659M | — | filing → | |
| 2026-06-30 | 56 | — | — | $655M | — | filing → | |
| 2026-06-30 | 43 | — | — | $653.9M | — | filing → | |
| 2026-06-30 | 34 | — | — | $651M | — | filing → | |
| 2026-06-30 | 84 | — | — | $605.6M | — | filing → | |
| 2026-06-30 | 73 | 4,200,000 | — | $600M | 1.50% | filing → | |
| 2026-06-30 | 64 | 1,900,000 | $315.79 | $600M | 0.90% | filing → | |
| 2026-06-30 | 80 | — | — | $543.9M | — | filing → |
Showing 1–50 of 500